Sign inJoin waitlistJoin the waitlist

Folashade Otegbeye

Facility Director & Head of Quality · University of Washington School of Medicine

Credentials: · · · · · · · ·

History

University of Washington School of Medicine
Present
University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Hematology and Medical Oncology
Case Western Reserve University/University Hospitals Cleveland Medical Center
2014–2017
Internal Medicine
Bridgeport Hospital
2011–2014
Harvard School of Public Health
Doctor of Medicine
2001–2005

Research

Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models
PLoS ONE · 2018 · First of 7 authors · Corresponding · 120 citations
Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma
Frontiers in Immunology · 2021 · 109 citations
Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells
Scientific Reports · 2019 · 104 citations

Marcos de Lima
23 papers
Paolo Caimi
17 papers
Brenda Cooper
16 papers
Leland Metheny
15 papers
Benjamin Tomlinson
14 papers
KB
Kirsten Boughan
11 papers
Molly Gallogly
11 papers
Ehsan Malek
10 papers
Hillard Lazarus
8 papers
David Wald
7 papers
Jiasheng Wang
3 papers · 3 as a fellow
Masumi Oshima
3 papers

Grants

Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $401.4K · Fred Hutchinson Cancer Center
1997–2029